This site is intended for health professionals only

Editor’s pick

Drug could fight many conditions
Drug could fight many conditions
Trust’s MRSA infections ‘eliminated’
Trust’s MRSA infections ‘eliminated’
Big pharma warns of mass exodus
Big pharma warns of mass exodus
Cell therapy trials approved
Cell therapy trials approved
Painkiller “too strong for market”
Painkiller “too strong for market”
Doubts over anti-abuse drug coating
Doubts over anti-abuse drug coating
EC and big pharma research grants
EC and big pharma research grants
Fear over drug-resistant superbug
Fear over drug-resistant superbug
Long-acting schizophrenia injection
Long-acting schizophrenia injection
International symposium on pharmaceutical research
International symposium on pharmaceutical research
Menveo trumps Menactra
Menveo trumps Menactra
Nanoparticle kills cancer cells
Nanoparticle kills cancer cells
1 … 197 198 199 200 201 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x